Complement downregulation promotes an inflammatory signature that renders colorectal cancer susceptible to immunotherapy.
Complement downregulation promotes an inflammatory signature that renders colorectal cancer susceptible to immunotherapy. J Immunother Cancer. 2022 09; 10(9).